Showing results (401-410 of 425) with videos related to
Sort By:
Pageof 43
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.Nature Communications|November 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trialAdrienne G Waks, Jingxin Fu, Xiangying Chu, et al.JCO Precision Oncology|July 7, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor BenefitRomualdo Barroso-Sousa, Juliet Forman, Katharine Collier, et al.Nature Communications|October 22, 2020
Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancersSherille D Bradley, Amjad H Talukder, Ivy Lai, et al.Annals of Surgery|November 2, 2023
Transforming the Future of Surgeon-ScientistsDaniela P Ladner, Allan M Goldstein, Timothy R Billiar, et al.Breast Cancer Research and Treatment|July 30, 2026
Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancerMegan E Tesch, Noah Graham, Craig Snow, et al.JAMA Oncology|April 27, 2023
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without PertuzumabCoralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, et al.Breast Cancer Research : BCR|January 31, 2024
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancerFilipa Lynce, Laura E Stevens, Zheqi Li, et al.Nature Cancer|March 19, 2021
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K Mehta, Emily M Cheney, Christina A Hartl, et al.Molecular Cell|August 18, 2018
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1Jong-Ho Cha, Wen-Hao Yang, Weiya Xia, et al.Pageof 43